The Impact of US FDA and Health Canada Warnings Related to the Safety of High-dose Simvastatin. (Record no. 27610251)

MARC details
000 -LEADER
fixed length control field 00840 a2200229 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517175019.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field ####s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2199-1154
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/s40801-017-0116-7
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Anand, Kanika
245 00 - TITLE STATEMENT
Title The Impact of US FDA and Health Canada Warnings Related to the Safety of High-dose Simvastatin.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Drugs - real world outcomes
Date of publication, distribution, etc. Dec 2017
300 ## - PHYSICAL DESCRIPTION
Extent 215-223 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sketris, Ingrid
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zhang, Ying
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Levy, Adrian
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gamble, John-Michael
773 0# - HOST ITEM ENTRY
Title Drugs - real world outcomes
Related parts vol. 4
-- no. 4
-- p. 215-223
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/s40801-017-0116-7">https://doi.org/10.1007/s40801-017-0116-7</a>
Public note Available from publisher's website

No items available.